Cancer Screening Costs Over $43 Billion a Year in the U.S., Study Estimates Colorectal cancer screening accounted for 64% of the total amount Aug 05, 2024
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies News, features, and commentary about cancer-related issues Aug 02, 2024
Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Risk News, features, and commentary about cancer-related issues Jul 26, 2024
FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials Committee unanimously backs mandating trial design to distinguish effects of therapy phases Jul 25, 2024
A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll News, features, and commentary about cancer-related issues Jul 12, 2024
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT News, features, and commentary about cancer-related issues Jul 05, 2024
Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer Discussion highlights insights from the LAURA trial and others on emerging treatments Jul 03, 2024 video
Vapers May Be Less Likely to Undergo Lung Cancer Screening "Former smokers who use e-cigarettes remain at increased risk of lung cancer," researchers say Jul 02, 2024
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials News, features, and commentary about cancer-related issues Jun 28, 2024
Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injury Case reports may not be as reliable, researchers say Jun 25, 2024
Court: Some Employers Can Exclude PrEP, Cancer Screenings From Insurance Coverage Not all preventive care recommended by the USPSTF is threatened by the narrow ruling, however Jun 24, 2024
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer News, features, and commentary about cancer-related issues Jun 21, 2024
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC No significant difference between atezolizumab-cabozantinib, docetaxel for OS, PFS, response Jun 20, 2024
Early Menopause Tied to Higher Risk of Respiratory Mortality Greatest risk observed for women with bilateral oophorectomy Jun 13, 2024
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break? News, features, and commentary about cancer-related issues Jun 13, 2024
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer Half of patients responded, but editorialists call for new directions in therapy development Jun 11, 2024
Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma Immunotherapy may have been given too late, researchers suggested Jun 10, 2024
Lung Cancer Screening Rates Remain Low in the U.S., Especially in the South But one study showed that patient navigation added to usual care may increase uptake Jun 10, 2024
Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patients Also in TTHealthWatch: diets and medicine in IBS and active surveillance in prostate cancer Jun 08, 2024 podcast
'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trial News, features, and commentary about cancer-related issues Jun 06, 2024
Industry Clinic 鈥� Ad Insights What Will It Take to Deliver Both Health & Care in Oncology? Jun 04, 2024
Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumab Median OS was 55.9 months in the durvalumab group compared with 33.4 months in the placebo group Jun 03, 2024
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC EGFR testing now needed for all patients with stage III disease, experts say Jun 02, 2024
Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer No differences observed in quality of life metric, patient and caregiver satisfaction Jun 02, 2024
Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLC Unexpectedly offers a possible overall survival benefit, researchers say Jun 01, 2024
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents China-based trial may present a hurdle to FDA approval, however Jun 01, 2024
Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer? News, features, and commentary about cancer-related issues May 31, 2024
Unprecedented PFS Results in ALK-Positive Lung Cancer Trial "We have not seen anything close to this," says expert May 31, 2024
Smoking Isn't the Only Source of Nicotine Addiction in Town Emerging data suggest pharmacological interventions may help patients quit vaping May 29, 2024
Ignoring Colonoscopy Advice; Inflamed Tongue, Then Cancer; Acupuncture for Dry Mouth News, features, and commentary about cancer-related issues May 24, 2024
Psychostimulant No Help in Relieving Cancer-Related Fatigue No significant differences in outcomes between methylphenidate, placebo May 22, 2024
Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound? News, features, and commentary about cancer-related issues May 17, 2024
FDA OKs Novel BiTE Agent for Small Cell Lung Cancer First-in-class tarlatamab achieved a 40% ORR in previously treated extensive-stage SCLC May 16, 2024
Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer CheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death May 15, 2024
Will AI Replace Radiologists, or Just Make Them Better Than Ever? Opinions differ on how much physicians should be embracing the technology May 14, 2024
Glecirasib Shows Promising Efficacy in KRAS-Mutated NSCLC Trend towards better response rate, PFS compared with approved KRAS inhibitors May 01, 2024
EPA Bans Consumer Use of Toxic Chemical Known to Cause Liver, Lung Cancers Methylene chloride has killed at least 88 workers since 1980 Apr 30, 2024
White House Indefinitely Delays Plan to Ban Menthol Cigarettes Biden administration has delayed the final rule several times recently Apr 26, 2024
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests News, features, and commentary about cancer-related issues Apr 19, 2024
Alectinib Lands FDA Approval for Adjuvant Therapy in NSCLC The ALK inhibitor reduced the risk of recurrence or death by 76% versus chemotherapy Apr 19, 2024
